Teva Pharmaceutical Industries Limited (TEVA) Discusses Anti-IL-15 Antibody Phase Ib 24-Week Efficacy Results in Vitiligo and Planned Advancement to Phase 2b July 7, 2026 8:00 AM EDT
Company Participants
Christopher Stevo – Senior Vice President of Investor Relations & Competitive Intelligence
Richard Francis – President, CEO & Director
Eric Hughes – Executive VP of Global R&D and Chief Medical Officer
Conference Call Participants
Yuchen Ding – Jefferies LLC, Research Division
Matthew Dellatorre – Goldman Sachs Group, Inc., Research Division
Jason Gerberry – BofA Securities, Research Division
David Amsellem – Piper Sandler & Co., Research Division
Louise Chen – Scotiabank Global Banking and Markets, Research Division
Christopher Schott – JPMorgan Chase & Co, Research Division
Di Zhao – UBS Investment Bank, Research Division
Umer Raffat – Evercore ISI Institutional Equities, Research Division
Presentation
Operator
Hello, and welcome to the IL-15 vitiligo Phase Ib 24-week Efficacy Results Conference Call. My name is Alex, and I’ll be coordinating today’s call.[Operator Instructions] I’ll now hand it over to Chris Stevo, SVP, Investor Relations. Please go ahead.
Christopher Stevo
Senior Vice President of Investor Relations & Competitive Intelligence
Thanks, Alex. Good morning and good afternoon, everyone. Before I turn the call over to our CEO, Richard Francis, I want to remind everyone that we will be making forward-looking statements on this call. The company cautions investors that any forward-looking statement involves risks and uncertainties and is not a guarantee of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements due to a variety of factors.
These factors are described in our earnings press release and our most recent 10-Q and 10-K filed with the SEC. And any statements we make are only as of today, and we undertake no obligation to update these statements subsequently. And with that, Richard Francis.
Richard Francis
President, CEO & Director







You must be logged in to post a comment Login